ArticleScientific reports2022

Metformin administration is associated with enhanced response to transarterial chemoembolization for hepatocellular carcinoma in type 2 diabetes patients.

Woo Jin Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.